Rybelsus is an oral medication that contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
Whether you are looking to lose weight or better manage your diabetes, these medications offer powerful options to help you achieve your health goals
In the STEP trials, participants who started semaglutide lost an average of 15 to 22% of their baseline body weight over 68 weeks
Biochemical Journal , 199 (3), 649-656
But the new Medicare benefit comes with caveats, particularly around clinical guidelines and what happens when the short-term program ends
Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America)